Cargando…
Sonic Hedgehog factor Gli1: As good as resistant
Chemoresistance remains a major impediment in cancer therapy. Although major progress has been made in understanding the mechanisms underlying resistance in cancer, there is still more to learn. Our studies provide evidence that Gli1 drives a novel form of drug resistance involving Phase II drug met...
Autores principales: | Zahreddine, Hiba Ahmad, Culjkovic-Kraljacic, Biljana, Borden, Katherine LB |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905224/ https://www.ncbi.nlm.nih.gov/pubmed/27308395 http://dx.doi.org/10.4161/23723548.2014.961827 |
Ejemplares similares
-
The sonic hedgehog factor Gli1 imparts drug resistance through inducible glucuronidation
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2014) -
G-Protein Gα(s) controls medulloblastoma initiation by suppressing sonic hedgehog signaling
por: He, Xuelian, et al.
Publicado: (2014) -
eIF4E3, a new actor in mRNA metabolism and tumor suppression
por: Volpon, Laurent, et al.
Publicado: (2013) -
The Impact of Post-transcriptional Control: Better Living Through RNA Regulons
por: Culjkovic-Kraljacic, Biljana, et al.
Publicado: (2018) -
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2017)